eISSN: 2084-9885
ISSN: 1896-6764
Neuropsychiatria i Neuropsychologia/Neuropsychiatry and Neuropsychology
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3-4/2022
vol. 17
 
Share:
Share:
Original article

Age, COVID-19-related fear, insomnia symptoms and cyberchondria: a mediation model

Włodzimierz Oniszczenko
1

1.
Faculty of Psychology, University of Warsaw, Poland
Online publish date: 2023/02/05
Article file
- Age COVID-19-related.pdf  [0.14 MB]
Get citation
 
PlumX metrics:
 

Introduction

The subject of our study was the relationship between cyberchondria and age, fear of COVID-19 infection and symptoms of insomnia. We have used the term ‘fear’ rather than ‘anxiety’ related to COVID-19 because, according to the DSM-5 classification, ‘fear’ is an emotional response to an actual or perceived threat, whereas ‘anxiety’ is the result of anticipating a future threat (American Psychiatric Association 2013).
Infection with the SARS-CoV-2 virus causes development of the infectious respiratory disease COVID-19, which, depending on its severity, may lead to pneumonia, respiratory failure and possibly even death (Adhikari et al. 2020). The potential COVID-19 mortality rate, fear of infection, and social limitations and changes leading to lockdowns and social isolation have resulted in numerous psychological and psychiatric consequences. Research on global responses to COVID-19 demonstrates that the pandemic has caused depression and anxiety symptoms, especially in women and younger people (COVID-19 Mental Disorders Collaborators 2021). For the Polish population in particular, Gambin et al. (2021) found that the highest levels of depression and anxiety related to the COVID-19 pandemic were observed in younger age groups (individuals 18-44 years old), and the lowest levels of depression and anxiety were seen in the 45-85-year-old age group. Those researchers also found that important predictors of depression and anxiety symptoms included difficulties in home relationships, fear, uncertainty about the spread of the virus, and external constraints.
Researchers have highlighted the need for closer examination of the lower levels of depression and anxiety symptoms – as well as post-traumatic stress disorder symptoms – in response to COVID-19 that have been found among the elderly, especially in developed countries. It is well known that older people have fewer coping resources for COVID-19; those resources include biological and cognitive resources as well as material resources (limited access to advanced information technology) and social resources (a small number of close people and friends) to help maintain their mental health (e.g., Farhang et al. 2022). On the other hand, older people can compensate for these gaps with closer and more meaningful social relationships, even with a small number of people, and they can benefit from the available professional medical and psychological care. Therefore, the level of anxiety and depression in response to the threat of the COVID-19 pandemic in this age group may not increase significantly (Vahia et al. 2020).
Chinese studies have shown that age and male gender, coexisting with somatic diseases, are significant factors in the development of severe forms of COVID-19 (Geng et al. 2021). Other studies, conducted at the epicentre of the COVID-19 pandemic in Wuhan, China, found that the risk factors for death in patients in local hospitals as a result of COVID-19 infection were age (more than 80 years old) and male gender, although these people had risk factors such as somatic diseases (cancerous, cardiological and neurological disorders) that are common to other age groups (Zhang et al. 2022). The importance of advanced age and male gender – and the presence of somatic diseases as risk factors for death due to COVID-19 infection – was also demonstrated in French studies (Kaeuffer et al. 2020) and a subsequent meta-analysis (Dessie and Zewotir 2021). A meta-analysis by Romero Starke et al. (2021) suggested that the risk of infection severity increases with age, but that it is not justified to introduce age thresholds in the COVID-19 severity analysis, as increases in infection severity can be observed in each age group.
Fear of COVID-19 infection can have two additional consequences. One is symptoms of insomnia, and the other is searching the Internet for information about the infection, its symptoms and treatments – a condition known as ‘cyberchondria’.
Some authors (e.g., Cheshmehzangi et al. 2022) point out that the health, social and economic challenges associated with the COVID-19 pandemic may disrupt sleep-regulating processes, such as circadian rhythms and brain activation processes, which in turn cause symptoms of insomnia. Bhat and Chokroverty (2022) demonstrated that the stress accompanying the fear of COVID-19 infection and the psychosocial factors associated with a pandemic (e.g., lockdown, quarantine and risk of economic problems) can lead to a range of sleep disorders, such as insomnia, interrupted sleep, a sense of non-regenerative sleep, daytime sleepiness and nightmares. To define the sleep disorder symptoms resulting from the COVID-19 pandemic, Bhat and Chokroverty (2022) proposed the colloquial term ‘coronasomnia’, and Gupta and Pandi-Perumal (2020) proposed the term ‘COVID-somnia’. A study by Goncalves et al. (2022) showed that younger women who fear COVID-19 infection and have relatively low incomes are particularly at risk of developing insomnia. However, a meta-analysis (Li et al. 2022) showed that insomnia primarily affects people prone to this type of disorder, such as healthcare workers, COVID-19 patients, patients with chronic somatic diseases and patients with mental disorders. In one of the studies, the researchers showed that alarmist media messages regarding the pandemic were also important factors in coronasomnia (Ot,elea et al. 2022).
Stress and fear about their own health and lives prompt people to search for information about disturbing symptoms, their significance and the treatment options. Internet resources become the source of easily available information. Starčević and Berle (2013) have described this phenomenon as ‘cyberchondria’. It is defined as a tendency to over-worry about one’s health and to increase Internet research for medical information about symptoms, which may be accompanied by general anxiety about health, doubts and the need to explain the symptoms. Indeed, excessive use of the Internet to search for information on health status may itself lead to an increase in anxiety (which resulted in the initial search) (Hashemi et al. 2020). The main predictors of cyberchondria are anxiety sensitivity, intolerance to uncertainty and obsessive-compulsive symptoms. According to Starčević et al. (2021), the development of cyberchondria during the pandemic resulted from high uncertainty about the medical and psychosocial consequences of the pandemic. As indicated by Laato et al. (2020), the excess of hard-to-distinguish information about the pandemic increased the feeling of anxiety and intensified cyberchondria. Research by Jungmann and Witthöft (2020) has shown that cyberchondria is positively correlated with fear of the SARS-CoV-2 virus, and this relationship is moderated by fear for one’s own health. Notably, the perceived susceptibility to COVID-19 infection has also been associated with cyberchondria, poor sleep quality, health anxiety and obsessive-compulsive symptoms (Yalçın et al. 2022). As indicated by Vismara et al. (2021), cyberchondria during the pandemic has increased, especially in women, young people, and people suffering from somatic diseases, depression and obsessive-compulsive symptoms, as well as problematic Internet users. The same study also showed that quality of life and self-esteem are inversely correlated with cyberchondria (Vismara et al. 2021). In turn, Maftei and Holman (2020) showed that in a group of older people, optimism – as opposed to neuroticism – reduces the likelihood of cyberchondria and the fear for one’s health. However, the lower frequency of cyberchondria in older age groups may result instead from the lower availability of IT techniques in this group or the lower skills of older people in using these techniques.
The aim of the current study was to determine the role of age, fear of COVID-19 infection and insomnia as predictors of cyberchondria in a Polish sample. We were also interested in whether insomnia mediates the relationship between fear of COVID-19 infection and cyberchondria in the entire sample. We hypothesised that age, fear of COVID-19 infection and insomnia would predict cyberchondria and that insomnia would serve as a moderator between COVID-19-related fear and cyberchondria.

Material and methods

Participants
The study sample consisted of 504 people aged 18-76 (M ±SD 30.49 ±10.28) comprising 420 women and 84 men. A detailed description of the study sample is presented in Table 1. Participants were recruited through an online platform. They were informed of the study’s purpose, that their participation was voluntary and that they could withdraw from participation at any time without needing to give a reason. Participants were not remunerated for their participation. Participants gave their informed consent to participate by proceeding to fill in the questionnaires.
Measures
Cyberchondria was assessed using the Polish version of the Cyberchondria Severity Scale (CSS) (McElroy and Shevlin 2014; Polish adaptation by Beata Bajcar, Jolanta Babiak and Agnieszka Olchowska-Kotala). The CSS comprises 33 items and uses a 5-point Likert scale (1 – never, 2 – rarely, 3 – sometimes, 4 – often, 5 – always). In this study, we considered the overall score for cyberchondria (Cronbach’s α = 0.93).
An 11-point numerical rating scale was used to measure the intensity of fear of COVID-19 infection for oneself. Each participant assessed the severity of fear they were experiencing at the time of testing by pointing to a number on a scale from 0 (I feel absolutely no fear) to 10 (I feel unimaginable fear).
Insomnia symptoms were measured using the Polish version of the Athenian Insomnia Scale (AIS) (Soldatos et al. 2000; Polish adaptation by Małgorzata Fornal-Pawłowska, Dorota Wołyńczyk-Gmaj and Waldemar Szelenberger). The AIS contains eight items that are scored from 0 to 3. The Cronbach’s α coefficient for this scale in the studied sample was 0.83.
Ethics
The research procedure strictly followed ethical principles for human research and was approved by the Research Ethics Committee at the University of Warsaw Faculty of Psychology (ref: 27-10-2020). All procedures followed were also in accordance with the Helsinki Declaration of 1975, as revised in 2000.
Statistics
All calculations were made using the IBM SPSS 27 software. To analyse cyberchondria predictors, multivariate hierarchical linear regression analyses were performed. Mediation analysis was performed via Hayes’ PROCESS macro version 4.1 (2018). Mediation analysis was carried out using the bootstrap method with 5000 sample draws (95% confidence intervals).

Results

As reflected in the data presented in Table 1, the proportion of women and men in this study was unequal. Women accounted for 83.7%, while men accounted for 16.3%. Most of the study participants were people with higher levels of education (63.5%), single (46.2%) or in marriage or partnerships (47.4%) and living in large cities (49.2%).
Table 2 contains data on descriptive statistics and Pearson’s correlations for the variables studied. The results of the descriptive statistical analysis presented in Table 2 confirmed the normality of the distribution of the results of COVID-19 fear, insomnia symptoms and cyberchondria. The age distribution was different from the normal one. As seen in Table 2, COVID-19-related fear and insomnia symptoms positively correlated with cyberchondria, while the correlation between age and cyberchondria was negative. Age positively correlated with COVID-19-related fear, while there was no significant correlation between age and insomnia symptoms. COVID-19-related fear positively correlated with insomnia symptoms.
In the hierarchical multivariate linear regression analysis, age (included in Step 1) was a non-significant predictor of cyberchondria. Age and fear of COVID-19 infection (included in the regression analysis in Step 2) explained 8% of the variance in cyberchondria. When a new predictor such as insomnia symptoms was added in Step 3, this predictor increased the explained cyberchondria variance by 1%. Overall, hierarchical multivariate linear regression analysis explained 9% of cyberchondria variability. The model was not burdened with the problem of collinearity (VIF, variance inflation factor values were between 1.0 and 1.3). The semipartial correlation coefficients indicated rather weak relationships between the predictors and cyberchondria (the highest correlation value was confirmed for the fear of COVID-19 infection) (Table 3).
To test the indirect relationship between COVID-19-related fear and the level of cyberchondria through insomnia symptoms, a mediation analysis was performed using the PROCESS macro version 4.1 (Model 4). The analysis indicated a significant indirect relationship between COVID-19-related fear and cyberchondria through insomnia symptoms [effect = 0.10, SE = 0.06, 95% CI = (0.00, 0.24)]. The individual pathways in the mediation analysis are displayed in Figure 1.

Discussion

Our hypothesis anticipated that age, fear of COVID-19 infection and insomnia would predict cyberchondria. We also hypothesised that insomnia would serve as a mediator between COVID-19-related fear and cyberchondria.
Results for the relationship between age and cyberchondria were inconsistent. In previous studies, Barke et al. (2016) and Fergus and Spada (2017) found no relationship between cyberchondria and age, whereas Laato et al. (2020) suggested that older people experienced less cyberchondria and were less likely to exchange unverified information regarding the pandemic.
Our results indicate that age, by itself, is not a predictor of cyberchondria. This result is not surprising. The risk of infection with SARS-CoV-2 applies to people of all ages and genders (Chen et al. 2022). Searching for information about one’s own health on the Internet does not result from advanced age, but rather from their health-anxiety level (Menon et al. 2020).
When the fear of COVID-19 infection was included in the regression analysis, age did materialise as a significant predictor of cyberchondria. It is likely that the fear of COVID-19 infection operates as a suppressor variable (i.e., a variable that increases the age-predictive value when introduced in the regression analysis) (MacKinnon et al. 2000). As illustrated in Table 3, the age effect is weak. The Pearson’s r correlation coefficient indicates that the relationship between age and cyberchondria is negative. The older a person is, the less they are involved in searching for information about their own health on the Internet. These observations are in line with the results of Maftei and Holman (2020), who also found a weak negative correlation between age and cyberchondria.
Fear of COVID-19 infection made the biggest contribution to the cyberchondria variability. While age and insomnia were weakly associated with cyberchondria, fear of COVID-19 infection made the greatest unique contribution to cyberchondria variability. Indeed, the fear of infection alone accounted for 8% of the variability in cyberchondria. The relationship between fear of COVID-19 and cyberchondria has also been demonstrated in several other studies (e.g., Wu et al. 2021; Uysal Toraman et al. 2022).
The various factors influencing the level of fear of COVID-19 infection include the current state of physical health, mental health problems and the fear of stigmatisation in the event of COVID-19 infection, as well as concern regarding COVID-19 information that is derived from the Internet (Vrublevska et al. 2022). It is worth emphasising that overly intensive searching for information on the Internet in response to the anxiety related to COVID-19 infection may intensify this fear. The Internet provides a great deal of incomplete, unverified and even false information (Hashemi et al. 2020). Individuals with greater IT competencies (mostly younger people) can cope better with information overload and pandemic anxiety (Robinson et al. 2021).
We believe that the increased fear of COVID-19 infection may play an important role in the development of insomnia. Cheshmehzangi et al. (2022) noted that the COVID-19 pandemic has caused numerous changes, such as changes in mental health (including those that induce fear and anxiety), changes in the social environment and important economic changes. All of these factors contribute to changes in circadian rhythms during a pandemic and can affect sleep regulation processes. Consequently, COVID-19 may become a source of qualitative and quantitative reduction in sleep quality. The increase in fear of COVID-19 infection is usually associated with changes in arousal levels and may contribute to sleep disturbances. Although our study showed that the link between insomnia and cyberchondria is rather weak, a mediation analysis confirmed that insomnia serves as a mediator in the relationship between fear of COVID-19 infection and cyberchondria.
Our multivariate hierarchical regression analysis also showed that insomnia was a weak but significant predictor of cyberchondria. High levels of insomnia symptoms have been associated with high levels of cyberchondria. Insomnia is a common health problem and is widespread among people of all ages, especially the elderly. Many researchers have pointed to various factors associated with insomnia, such as somatic diseases or psychotic disorders, but a special role in its development has been played by mood disorders and anxiety disorders (Aernout et al. 2021). We expect that during a pandemic, the symptoms of insomnia, when they are particularly severe and frequent, may prompt people to search the Internet for information about the relationship between insomnia and the pandemic and how to cope with it.
Our study had some limitations. First, the studied sample was not balanced in terms of gender. Women predominated among the participants, which limits the generalisability of the study results. Second, we did not control for the presence of physical and mental health disorders among study participants, which could have influenced scores on COVID-19-related fear as well as symptoms of insomnia. Third, a significant portion of the participants were well-educated people living in large cities, which could have influenced their assessment of the pandemic. Fourth, mediation analysis also requires verification to assess whether the results reflect mediating or confounding factors (MacKinnon et al. 2000). Considering these limitations, we suggest future qualitative and quantitative research for a stronger assessment of the studied relationships.

Conclusions

Despite these limitations, we observed that COVID-19-related fear and, to a lesser extent, age and insomnia are cyberchondria predictors. We also found both direct and indirect relationships between COVID-19-related fear and cyberchondria through insomnia.

Acknowledgements

This work was supported by the University of Warsaw Faculty of Psychology via funds awarded by the Ministry of Science and Higher Education in the form of a subsidy for the maintenance and development of research potential in 2021 and, partially, 2022 No 501-D125-01-1250000. This research did not receive any specific grants from funding agencies in the public, commercial or not-for-profit sectors.

Disclosure

The author declares no conflict of interest.

References

1. Adhikari SP, Meng S, Wu YJ, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty 2020; 9: 29.
2. Aernout E, Benradia I, Hazo JB, et al. International study of the prevalence and factors associated with insomnia in the general population. Sleep Med 2021; 82: 186-192.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Publishing, Arlington, VA 2013.
4. Barke A, Bleichhardt G, Rief W, Doering BK. The Cyberchondria Severity Scale (CSS): German validation and development of a short form. Int J Behav Med 2016; 23: 595-605.
5. Bhat S, Chokroverty S. Sleep disorders and COVID-19. Sleep Med 2022; 91: 253-261.
6. Chen B, Li QX, Zhang H, et al. The psychological impact of COVID-19 outbreak on medical staff and the general public. Curr Psychol 2022; 41: 5631-5639.
7. Cheshmehzangi A, Chen H, Su Z, et al. How does the COVID-19 fuel insomnia? Brain Behav Immun Health 2022; 21: 100426.
8. COVID-19 Mental Disorders Collaborators. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet 2021; 398: 1700-1712.
9. Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: A systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis 2021; 21: 855.
10. Farhang M, Miranda-Castillo C, Behrens MI, et al. Impact of social isolation and coping strategies in older adults with mild cognitive impairment during the covid-19 pandemic: A qualitative study. Aging Ment Health 2022; 26: 1395-1416.
11. Fergus TA, Spada MM. Cyberchondria: Examining relations with problematic Internet use and metacognitive beliefs. Clin Psychol Psychother 2017; 24: 1322-1330.
12. Gambin M, Sękowski M, Woźniak-Prus M, et al. Generalized anxiety and depressive symptoms in various age groups during the COVID-19 lockdown in Poland. Specific predictors and differences in symptoms severity. Compr Psychiatry 2021; 105: 152222.
13. Geng MJ, Wang LP, Ren X, et al. Risk factors for developing severe COVID-19 in China: An analysis of disease surveillance data. Infect Dis Poverty 2021; 10: 48.
14. Goncalves M, Henriques A, Costa AR, et al. Insomnia and nightmare profiles during the COVID-19 pandemic in Portugal: characterization and associated factors. Sleep Med 2022; 90: 44-52.
15. Gupta R, Pandi-Perumal SR. COVID-somnia: How the pandemic affects sleep/wake regulation and how to deal with it? Sleep Vigil 2020; 4: 51-53.
16. Hashemi SGS, Hosseinnezhad S, Dini S, et al. The mediating effect of the cyberchondria and anxiety sensitivity in the association between problematic internet use, metacognition beliefs, and fear of COVID-19 among Iranian online population. Heliyon 2020; 6: e05135.
17. Hayes AF. Introduction to mediation, moderation, and conditional process analysis: A regression-based approach. 2nd ed. The Guilford Press, New York 2018.
18. Jungmann SM, Witthöft M. Health anxiety, cyberchondria, and coping in the current COVID-19 pandemic: Which factors are related to coronavirus anxiety? J Anxiety Disord 2020; 73: 102239.
19. Kaeuffer C, Le Hyaric C, Fabacher T, et al. Clinical characteristics and risk factors associated with severe
20. COVID-19: Prospective analysis of 1,045 hospitalised cases in North-Eastern France, March 2020. Euro Surveill 2020; 25: 2000895.
21. Laato S, Najmul Islam AKM, Nazrul Islam M, Whelan E. What drives unverified information sharing and cyberchondria during the COVID-19 pandemic? Eur J Inf Syst 2020; 29: 288-305.
22. Li Y, Chen B, Hong Z, et al. Insomnia symptoms during the early and late stages of the COVID-19 pandemic in China: A systematic review and meta-analysis. Sleep Med 2022; 91: 262-272.
23. MacKinnon DP, Krull JL, Lockwood CM. Equivalence of the mediation, confounding and suppression effect. Prev Sci 2000; 1: 173-181.
24. Maftei A, Holman AC. Cyberchondria during the coronavirus pandemic: The effects of neuroticism and optimism. Front Psychol 2020; 11: 567345.
25. McElroy E, Shevlin M. The development and initial validation of the Cyberchondria Severity Scale (CSS). J Anxiety Disord 2014; 28: 259-265.
26. Menon V, Kar SK, Tripathi A, et al. Cyberchondria: Conceptual relation with health anxiety, assessment, management and prevention. Asian J Psychiatr 2020; 53: 102225.
27. Oţelea MR, Zugravu C, Rașcu A, et al. Coronasomnia in employees without a direct contact with COVID-19 infected patients in their workplace. Healthcare (Basel) 2022; 10: 1194.
28. Robinson L, Schulz J, Wiborg ØN, Johnston E. The COVID connection: Pandemic anxiety, COVID-19 comprehension, and digital confidence. Am Behav Sci 2021; 65: 1721-1746.
29. Romero Starke K, Reissig D, Petereit-Haack G, et al. The isolated effect of age on the risk of COVID-19 severe outcomes: A systematic review with meta-analysis. BMJ Glob Health 2021; 6: e006434.
30. Soldatos CR, Dikeos DG, Paparrigopoulos TJ. Athens Insomnia Scale: Validation of an instrument based on ICD-10 criteria. J Psychosom Res 2000; 48: 555-560.
31. Starčević V, Berle D. Cyberchondria: Towards a better understanding of excessive health-related Internet use. Expert Rev Neurother 2013; 13: 205-213.
32. Starčević V, Schimmenti A, Billieux J, Berle D. Cyberchondria in the time of the COVID-19 pandemic. Hum Behav Emerg Technol 2021; 3: 53-62.
33. Uysal Toraman A, Kalkim A, Korkmaz EK. Coronavirus anxiety and cyberchondria among teachers during the COVID-19 pandemic: An online survey: Coronavirus anxiety and cyberchondria [published online ahead of print, 2022 Jul 16]. Curr Psychol 2022; 1-7.
34. Vahia IV, Jeste DV, Reynolds CF 3rd. Older adults and the mental health effects of COVID-19. JAMA 2020; 324: 2253-2254.
35. Vismara M, Vitella D, Biolcati R, et al. The impact of COVID-19 pandemic on searching for health-related information and cyberchondria on the general population in Italy. Front Psychiatry 2021; 12: 754870.
36. Vrublevska J, Perepjolkina V, Martinsone K, et al. Determinants of anxiety in the general Latvian population during the COVID-19 state of emergency. Front Public Health 2022; 10: 854812.
37. Wu X, Nazari N, Griffiths MD. Using fear and anxiety related to COVID-19 to predict cyberchondria: Cross-sectional survey study. J Med Internet Res 2021; 23: e26285.
38. Yalçın İ, Boysan M, Eşkisu M, Çam Z. Health anxiety model of cyberchondria, fears, obsessions, sleep quality, and negative affect during COVID-19 [published online ahead of print, 2022 Mar 14]. Curr Psychol 2022; 1-18.
39. Zhang H, Wu Y, He Y, et al. Age-related risk factors and complications of patients with COVID-19: A population-based retrospective study. Front Med (Lausanne) 2022; 8: 757459.
Copyright: © 2023 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.